What is the recommended amount of fluid to remove during paracentesis before administering albumin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Administration After Paracentesis

Albumin should be administered after paracentesis when more than 5 liters of ascitic fluid is removed, at a dose of 6-8 g of albumin per liter of fluid removed. 1

Paracentesis Volume and Albumin Requirements

Large Volume Paracentesis (>5 L)

  • Definite albumin requirement: Strong evidence supports albumin administration for paracentesis >5 L 1
  • Recommended dose: 6-8 g of albumin per liter of ascitic fluid removed 1
  • Example calculation: For 8 L removal = 8 L × 8 g/L = 64 g albumin (equivalent to 320 mL of 20% albumin solution or 256 mL of 25% albumin solution) 2

Small Volume Paracentesis (<5 L)

  • Conditional albumin requirement: Consider albumin administration in patients with:
    • Acute-on-chronic liver failure (ACLF)
    • High risk of post-paracentesis acute kidney injury 1
    • Same dosing of 6-8 g/L if administered

Clinical Rationale for Albumin Administration

Albumin administration prevents post-paracentesis circulatory dysfunction (PPCD), which is associated with:

  • Increased recurrence of ascites
  • Development of hepatorenal syndrome
  • Hyponatremia
  • Reduced survival 1

A meta-analysis of 17 randomized studies (1,225 patients) showed albumin infusion reduces:

  • Risk of PPCD by 61% (OR = 0.39,95% CI 0.27-0.55)
  • Hyponatremia by 42% (OR = 0.58,95% CI 0.39-0.87)
  • Mortality by 36% (OR = 0.64,95% CI 0.41-0.98) 1

Volume Limitations and Special Considerations

  • Maximum recommended volume: Limit ascites removal to <8 L per session when possible, as risk of PPCD increases with >8 L removed in one session 1
  • Administration timing: Albumin should be infused after paracentesis is completed 2
  • Infusion rate: Administer albumin slowly to prevent potential cardiac overload, especially in patients with pre-existing cardiomyopathy 1, 2

Alternative Plasma Expanders

Non-albumin plasma expanders (dextran, hydroxyethyl starch, gelatin, hypertonic saline) are less effective than albumin in preventing PPCD 1, 3.

Special Situations

  • Some evidence suggests half-dose albumin (4 g/L) might be effective in selected patients with low severity cirrhosis (MELD score 16-17), but this approach is not currently recommended in guidelines 4
  • For patients with spontaneous bacterial peritonitis, a different albumin dosing regimen is recommended (1.5 g/kg on day 1 and 1 g/kg on day 3) 1

Clinical Pitfalls to Avoid

  • Don't underestimate fluid volume: Accurately measure removed ascitic fluid to calculate proper albumin dose
  • Don't skip albumin for >5 L removal: The cost of albumin should not deter its use when indicated
  • Don't remove excessive volumes: Consider limiting single-session paracentesis to <8 L to reduce PPCD risk
  • Don't administer too rapidly: Infuse albumin slowly to prevent circulatory overload

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Paracentesis and Albumin Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.